[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.113.179. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
January 2003

Visibility of Neurofibromatosis 1 and Psychiatric Morbidity

Author Affiliations

Not Available

Arch Dermatol. 2003;139(1):103-104. doi:10.1001/archderm.139.1.103

Psychiatric comorbidities have been well documented in patients with neurofibromatosis 1 (NF1),13 and none of these psychological or psychiatric conditions are correlated with the severity of somatic symptoms.2,3 We recently published in the ARCHIVES that NF1 has a significant impact on quality of life through alteration of health and appearance.4 While conducting this quality-of-life study, we evaluated the impact of NF1 visibility and severity on psychiatric morbidity.

×